GoodRx Adjusts CEO Contract and Announces Board Changes
Company Announcements

GoodRx Adjusts CEO Contract and Announces Board Changes

GoodRx Holdings (GDRX) has issued an update.

GoodRx Holdings, Inc. has updated its employment agreement with Interim CEO Scott Wagner, now offering him an indefinite term with the potential for an annual cash incentive bonus equal to his base salary, based on performance goals set by the Board. Wagner is also set to receive generous severance benefits under certain conditions and has been awarded $8 million in equity incentives, vesting monthly over eight installments starting May 2024, contingent on ongoing employment. Additionally, Board members Adam Karol and Stephen LeSieur have resigned, with no disagreements cited regarding the company’s operations or practices.

See more data about GDRX stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyGoodRx price target lowered to $7 from $10 at Citi
TheFlyGoodRx price target lowered to $6 from $10 at Barclays
TheFlyGoodRx management to meet virtually with KeyBanc
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App